Ventricular Remodeling Clinical Trial
Official title:
Effect of Recombinant Human Brain Natriuretic Peptide on Ventricular Remodeling and Cardiac Function in Patients With Acute Anterior Myocardial Infraction Undergoing Percutaneous Coronary Intervention
This study is designed to evaluate the efficacy and safety of Recombinant Human Brain Natriuretic Peptide (rhBNP) in improving ventricular remodeling and cardiac function after acute anterior myocardial infarction undergoing percutaneous coronary intervention. 100 patients with acute anterior myocardial infarction after primary Percutaneous Coronary Intervention (pPCI) are randomly assigned 1:1 to rhBNP group(n=50) and control group(n=50) with follow-up of 24 weeks. Both groups are treated with standard therapy of AAMI, with the rhBNP group intravenous dripping rhBNP after pPCI for 3 days and the control group treated with placebo at the same time. The primary endpoint is the change in N terminal pro-B-type natriuretic peptide（NT-proBNP ）and cardiac troponin T(cTnT) level.The secondary endpoint is the change in 24-week echocardiographic including left ventricle ejection fraction (LVEF) , left ventricular end-diastolic volume index (LVEDVI) and left ventricular end-systolic volume index (LVESVI), arrhythmia and cardiovascular events (death, cardiac arrest or cardiopulmonary resuscitation, hospitalization due to heart failure or angina pectoris).
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Not yet recruiting |
NCT04068116 -
Impact of Ischemic Post-conditioning
|
N/A | |
| Recruiting |
NCT05934071 -
Effects of the Sodium-glucose Cotransporter 2 Inhibitors+Sacubitril/Valsartan Therapy in Patients With HFrEF.
|
||
| Completed |
NCT02973594 -
Pulse Reduction On Beta-blocker and Ivabradine Therapy
|
Phase 4 | |
| Enrolling by invitation |
NCT04067635 -
Primary Mitral Regurgitation Repair
|
||
| Not yet recruiting |
NCT06343844 -
Disparities in Myocardial Infarction Remodeling According to Gender
|
N/A | |
| Completed |
NCT00687206 -
Efficacy and Safety of Valsartan Plus Hydrochlorothiazide in Patients With Slight Hypertension and Target Organ Damage
|
Phase 4 | |
| Active, not recruiting |
NCT05973591 -
The Impact of Ivabradine on Left Ventricular Reverse Remodeling in Nonischemic Dilated Cardiomyopathy (NIDCM) on Current Medical Therapy Era
|
||
| Completed |
NCT01305304 -
Magnetic Resonance Technique in the Assessment of Exercise-induced Long- and Short-Term Changes in Cardiac Function and Morphology
|
N/A | |
| Completed |
NCT04397302 -
Role of Sacubitril/Valsartan in the Improvement of Heart Failure With Reduced Ejection Fraction
|
||
| Completed |
NCT04161378 -
Impact of Cardiac Rehabilitation Programs on Left Ventricular Remodeling After Acute Myocardial Infarction - the REHAB Trial
|
||
| Completed |
NCT00288665 -
Thrombectomy and Improvement of Left Ventricular Function in AMI
|
Phase 4 |